Marpai, Inc.
MRAI Healthcare Healthcare Plans
Marpai, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.1 million, down 35.8% from fiscal 2024. In the quarter to June 2026, revenue fell 10.5%, EPS grew 35.7%, free cash flow fell 27.7% and total debt fell 20.3%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow MRAI
Marpai, Inc. (MRAI) EV/Sales
As of 16 October 2026, Marpai, Inc. (MRAI) trades at a EV/Sales of 5.1×. Over the past ten years it has ranged from −0.3× (September 2023) to 6.6× (September 2026); the current reading is higher than 98% of that period. That is above the Healthcare Plans industry median of 0.4× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.0× | 175.64% |
| FY2024 | 0.4× | 359.56% |
| FY2023 | 0.1× | — |
| FY2022 | −0.1× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | 92.55% |
| Mar 2026 | 0.8× | (26.00%) |
| Dec 2025 | 1.0× | (4.03%) |
| Sep 2025 | 1.1× | (0.81%) |
| 17 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CNC Centene Corporation compare | 0.1× |
| MOH Molina Healthcare, Inc compare | 0.1× |
| HUM Humana Inc. compare | 0.3× |
| ALHC Alignment Healthcare, Inc. compare | 0.3× |
| CI Cigna Group compare | 0.4× |
| OSCR Oscar Health, Inc. compare | 0.4× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| PGNY Progyny, Inc. compare | 1.4× |
| MRAI Marpai, Inc. | 5.1× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)